Schnell Biopharmaceuticals Incorporation operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Schnell Biopharmaceuticals Incorporation with three other
companies in this sector in South Korea:
DHP Korea Co Ltd
sales of 38.56 billion Korean Won [US$32.74 million]
Kyung Nam Pharm Company Limited
(39.09 billion Korean Won [US$33.19 million]
Humedix Co Ltd
(42.13 billion Korean Won [US$35.77 million]
During the year ended December of 2015, sales at
Schnell Biopharmaceuticals Incorporation were 40.32 billion Korean Won (US$34.24 million).
increase of 21.9%
versus 2014, when the company's sales were 33.09 billion Korean Won.